C9160 HCPCS Level II code: Injection, daxibotulinumtoxina-lanm, 1 unit
CMS terminated C9160: its last date of service was Mar 31, 2024. It stays here for looking up older claims; newer services need a current code.
Official description
C9160Injection, daxibotulinumtoxina-lanm, 1 unit
Short description: Inj daxibotulinumtoxina-lanm
HCPCS · United States
Medicare details
The indicators CMS publishes with C9160 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Medical care; Ambulatory surgical center (facility usage for surgical services)
- BETOS category
- Other drugs
- Coverage statute
- 1833(T)
- Added
- Jan 1, 2024
- Terminated after
- Mar 31, 2024
Where C9160 sits
- 1C codesOutpatient prospective payment system
- 2Terminated C9160Injection, daxibotulinumtoxina-lanm, 1 unit
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code C9160 still valid?
No. CMS terminated C9160; its last date of service was Mar 31, 2024. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover C9160?
CMS lists C9160’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9160
All C codesC9154Injection, buprenorphine extended-release (brixadi), 1 mgC9155Injection, epcoritamab-bysp, 0.16 mgC9156Flotufolastat f 18, diagnostic, 1 millicurieC9157Injection, tofersen, 1 mgC9158Injection, risperidone, (uzedy), 1 mgC9159Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activityC9161Injection, aflibercept hd, 1 mgC9162Injection, avacincaptad pegol, 0.1 mgC9163Injection, talquetamab-tgvs, 0.25 mgC9164Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)C9165Injection, elranatamab-bcmm, 1 mgC9166Injection, secukinumab, intravenous, 1 mg